Trinseo (NYSE: TSE), the global materials company and manufacturer of plastics, latex binders and synthetic rubber, will exhibit at Medical Manufacturing Asia 2016 from August 31 – September 2, at Marina Bay Sands, Singapore at Booth 2L–16.
Trinseo has served the global medical devices market for nearly three decades. Part of the Dow Chemical Company until 2010, the company offers worldwide production and fulfillment, and recently introduced its medical compounding capability in Asia Pacific to complement its existing compounding in Europe and North America. These facilities are sourced with polycarbonate base resins from Trinseo’s highest quality, medically-equivalent resins produced in Germany and from its joint venture partner in Japan.
These materials address some of the industry’s critical challenges, including the miniaturization of medical instruments, the increase in home health care and point-of-care treatment, and the need to produce lighter weight devices.
Interested in arranging a meeting with Trinseo at Medical Manufacturing Asia 2016 in Singapore? Contact Gregory Seah at firstname.lastname@example.org.
Trinseo (NYSE: TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber. We are focused on delivering innovative and sustainable solutions to help our customers create products that touch lives every day — products that are intrinsic to how we live our lives — across a wide range of end-markets, including automotive, appliances, consumer electronics, medical devices, electrical, building and construction, textile, paper and board, footwear and tires. Trinseo had approximately $4.4 billion in net sales in 2017, with 16 manufacturing sites around the world, and approximately 2,200 employees. For more information visit www.trinseo.com
Für weitere Informationen über die Richtlinien von Trinseo benutzen Sie bitte diese Links: